INVO Bioscience (IVOB)

About

Here's What The Experts Are Saying

Steven Shum

Steven Shum

President and CEO INVO Bioscience, Inc. (IVOB)

View LinkedIn

"We are excited with the progress being made to drive revenue growth domestically through our...

Read more
Pressly Ahammed

Pressly Ahammed

Director International Business Development at INVO Bioscience, Inc. (IVOB)

View LinkedIn

"We are extremely pleased to have established commercialization agreements with Orcan Medical...

Read more

Video's

  • INVOCell Simplifying IVF Discussed By & With Atlantic Reproductive Medicine Specialists

  • INVOCELL IVF IS AN ENTIRELY NEW FDA APPROVED METHOD OF PERFORMING FERTILITY TREATMENTS FOR INFERTILE COUPLES WHICH IS MORE NATURAL, SIMPLER AND COSTS 50% LESS THAN CONVENTIONAL IVF TREATMENT.

  • INVOCell Testimonial by Katie & Jk From Atlantic Reproductive Medicine Specialists

News Around The Web

  • No News
Show More

Vista Exclusive Content

INVO Bioscience, Developers of INVOcell® (The World’s Only In Vivo Intravaginal Culture System), Reports Q3 Progress
Nov 14, 2019

INVO Bioscience, Developers of INVOcell® (The World’s Only In Vivo Intravaginal Culture System), Reports Q3 Progress

Read More
INVO Bioscience (IVOB) Signs First JV To Operate Dedicated INVOcell Fertility Clinics in India
Jan 16, 2020

INVO Bioscience (IVOB) Signs First JV To Operate Dedicated INVOcell Fertility Clinics in India

Read More
INVO Bioscience Enters New Commercialization Agreements For INVOcell®, The World's Only In Vivo Intravaginal Culture System, In Eurasia (Turkey & Jordan)
Nov 13, 2019

INVO Bioscience Enters New Commercialization Agreements For INVOcell®, The World's Only In Vivo Intravaginal Culture System, In Eurasia (Turkey & Jordan)

Read More
New Type of IVF Treatment From Newcomer INVO Bioscience Is Headed To Reno
Nov 21, 2019

New Type of IVF Treatment From Newcomer INVO Bioscience Is Headed To Reno

Read More
INVO Bioscience, Developers Of The World’s Only In Vivo FDA Cleared Intravaginal Culture System, Will Host A Live Investor Webcast at 11:00 AM ET (8:00 am PT) on Thursday, November 21, 2019
Nov 19, 2019

INVO Bioscience, Developers Of The World’s Only In Vivo FDA Cleared Intravaginal Culture System, Will Host A Live Investor Webcast at 11:00 AM ET (8:00 am PT) on Thursday, November 21, 2019

Read More
View All

Emerging Opportunities

Choose one of the above emerging opportunities to learn more today

View All

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us